Use of GLP-1 receptor drugs and sudden non-artery-related vision loss: an example case

Non-arteritic anterior ischaemic optic neuropathy may occur following exposure to glucagon-like peptide-1 receptor agonists.

• The occurrence of non-arteritic anterior ischaemic optic neuropathy is noted in patients using glucagon-like peptide-1 receptor agonists.
• A direct causal relationship between these medications and the condition has not been established.
• Further investigation is needed to understand the potential link between the drug class and the optic neuropathy.

Simplified